医学
内科学
队列
肺癌
临床终点
临床试验
肿瘤科
队列研究
作者
Julien Mazières,Paul K. Paik,Marina Chiara Garassino,Xiuning Le,Hiroshi Sakai,R. Veillon,Egbert F. Smit,Alexis B. Cortot,Jo Raskin,Santiago Viteri,Yi‐Long Wu,James Chih‐Hsin Yang,Myung‐Ju Ahn,Rui Ma,Jun Zhao,Aurora O’Brate,Karin Berghoff,Rolf Bruns,Gordon Otto,Andreas Johne
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2023-06-04
卷期号：9 (9): 1260-1260
被引量：57
标识
DOI：10.1001/jamaoncol.2023.1962
摘要
MET inhibitors have recently demonstrated clinical activity in patients with MET exon 14 (METex14)-skipping non-small cell lung cancer (NSCLC); however, data with longer follow-up and in larger populations are needed to further optimize therapeutic approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
SYLH
彭于彦祖
yznfly
鸣笛
ED
herococa
zho
CR7
柯一一
liu
乐观小之
热心市民小红花
SHAO
pluto
孙燕
eric888
大脑袋
Billy
司空豁
挖掘机
皖公网安备34019202002308
